Severe aplastic anaemia after serial vaccinations for SARS‐CoV‐2, pneumococcus and seasonal influenza
Abstract We present a 67‐year‐old woman who developed progressive pancytopenia over 10 months, concomitant with administration of severe adult respiratory syndrome coronavirus‐2 (SARS‐CoV‐2), pneumococcal and influenza vaccines. She developed mild leukopenia ∼2 weeks after the SARS‐CoV‐2 mRNA vaccine sequence, with progressive symptoms after subsequent vaccines, eventually developing severe aplastic anaemia (SAA). While there have been several reports of vaccine‐related SAA, at time of submission, our case is the first reported to develop after the Moderna mRNA SARS‐CoV‐2 vaccine, as well as the first to document the gradual development of SAA over the course of many vaccine exposures. Physicians should be cognizant of vaccine‐associated SAA, considering current widespread coronavirus disease 2019 vaccination efforts..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:3 |
|---|---|
| Enthalten in: |
eJHaem - 3(2022), 3, Seite 983-988 |
| Beteiligte Personen: |
Wang, Xiao [VerfasserIn] |
|---|
| Anmerkungen: |
© 2022 British Society for Haematology and John Wiley & Sons Ltd. |
|---|
| Umfang: |
6 |
|---|
| doi: |
10.1002/jha2.443 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
WLY008819181 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | WLY008819181 | ||
| 003 | DE-627 | ||
| 005 | 20231111174758.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230217s2022 xx |||||o 00| ||und c | ||
| 024 | 7 | |a 10.1002/jha2.443 |2 doi | |
| 028 | 5 | 2 | |a 2023-11-11_JHA2_2022_3_3.zip.xml |
| 035 | |a (DE-627)WLY008819181 | ||
| 035 | |a (WILEY)JHA2443 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 100 | 1 | |a Wang, Xiao |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Severe aplastic anaemia after serial vaccinations for SARS‐CoV‐2, pneumococcus and seasonal influenza |
| 264 | 1 | |c 2022 | |
| 300 | |a 6 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © 2022 British Society for Haematology and John Wiley & Sons Ltd. | ||
| 520 | |a Abstract We present a 67‐year‐old woman who developed progressive pancytopenia over 10 months, concomitant with administration of severe adult respiratory syndrome coronavirus‐2 (SARS‐CoV‐2), pneumococcal and influenza vaccines. She developed mild leukopenia ∼2 weeks after the SARS‐CoV‐2 mRNA vaccine sequence, with progressive symptoms after subsequent vaccines, eventually developing severe aplastic anaemia (SAA). While there have been several reports of vaccine‐related SAA, at time of submission, our case is the first reported to develop after the Moderna mRNA SARS‐CoV‐2 vaccine, as well as the first to document the gradual development of SAA over the course of many vaccine exposures. Physicians should be cognizant of vaccine‐associated SAA, considering current widespread coronavirus disease 2019 vaccination efforts. | ||
| 700 | 1 | |a Laczko, Dorottya |4 aut | |
| 700 | 1 | |a Caponetti, Gabriel C. |4 aut | |
| 700 | 1 | |a Rabatin, Susan |4 aut | |
| 700 | 1 | |a Babushok, Daria V. |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t eJHaem |g 3(2022), 3, Seite 983-988 |w (DE-627)WLY008814953 |x 26886146 |7 nnns |
| 773 | 1 | 8 | |g volume:3 |g year:2022 |g number:3 |g pages:983-988 |g extent:6 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_WLY | ||
| 951 | |a AR | ||
| 952 | |d 3 |j 2022 |e 3 |h 983-988 |g 6 | ||